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Quetiapine is an atypical antipsychotic agent which is being increasingly prescribed for psychotic
disorders because it has fewer side effects than other antipsychotics. Consequently, overdoses of que-
tiapine have gained attention, given its widespread use. We report a 31-year-old man with schizophrenia
who allegedly ingested 4 g of immediate-release quetiapine. He presented with common manifestations
of quetiapine overdose such as sinus tachycardia, dry mouth and mucosa, hypotension, and coma. He also
had hyperglycemia and late onset seizures (>24 hours post ingestion) which are not frequently reported.
The patient was given activated charcoal while hypotension was managed with ﬂuid resuscitation and
intravenous noradrenaline. Intravenous diazepam and phenytoin were given for the seizure. The patient
recovered without residual complications. Although a quetiapine overdose can result in serious medical
complications, it can be managed by early intervention, mainly supportive care and close monitoring.
Copyright  2012, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
Quetiapine is a dibenzothiazepine atypical antipsychotic agent
which has a higher afﬁnity for 5-hydroxytryptamine (HT)2 recep-
tors than dopamine (D)2 receptors [1,2]. Thus, it has fewer extra-
pyramidal side effects than typical antipsychotics and has become
widely prescribed for schizophrenia and bipolar disorders. Never-
theless, an overdose of quetiapine has serious medical conse-
quences although the fatality rate is low [2]. Previous case series
and case reports revealed that central nervous system depression
and tachycardia are more common clinical manifestations of que-
tiapine overdose while hypotension, respiratory depression, pro-
longed QT and QRS intervals and seizures are infrequent [1e5].
Hyperglycemia and late-onset seizures are even less documented
and can only be found in a very few case reports [4,5]. Here we
describe a case of quetiapine overdose manifesting with hyper-
glycemia and late-onset seizures.2. Case report
A 31-year-old, approximately 60 kg man with schizophrenia
allegedly ingested 40 tablets of 100-mg immediate-releaseharmacy, School of Pharma-
Minden, Penang, Malaysia.
.
ddhist Compassion Relief Tzu Chiquetiapine (total dose 4 g). Hewas found unresponsive at home and
was subsequently admitted to the casualty unit. He had been
prescibed quetiapine 300 mg per day for schizophrenia and had no
other medical diseases.
The patient presented with a Glasgow Coma Scale score of 3,
dry mouth and mucosa, hyperglycemia (random blood glucose
level of 17.0 mmol/L) and a respiratory rate of 16 breaths per
minute. He was hemodynamically unstable with a blood pressure
of 97/42 mmHg which later decreased to 73/30 mmHg. The
patient was given 50 g of activated charcoal and ﬂuid resuscita-
tion. He was then transferred to the general intensive care unit
(GICU) for respiratory support and close observation. Later that
day, he developed sinus tachycardia at 121 beats per minute. A
complete blood count showed a slightly low hematocrit of 37.9%,
normal white blood count of 9.4  103/mL and normal platelet
count of 222  103/mL. The renal proﬁle showed a calculated
creatinine clearance of 113.54 mL/min, while serum electrolyte
analysis revealed a borderline low sodium level of 132 mmol/L,
potassium of 3.6 mmol/L, and magnesium of 0.8 mmol/L. The
patient’s coagulation values were normal with a prothrombin time
of 11.0 seconds, activated partial thromboplastin time of 25.0
seconds, and international normalized ratio of 1.0. Liver function
tests showed normal values for alanine aminotransferase (17 U/L)
and alkaline phosphatase (47 U/L). Levels of creatine kinase
(171 U/L), lactate dehydrogenase (214 U/L), and aspartate amino-
transferase (24 U/L) were elevated. His arterial blood gas proﬁle
showed slight metabolic acidosis (pH 7.31, pCO2 44 mmHg and
HCO3 22.2 mmol/L), which normalized on Day 2. His bloodFoundation. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Random blood glucose level throughout hospital admission.









M.F.-C. Yam et al. / Tzu Chi Medical Journal 25 (2013) 119e121120glucose level normalized within one day of GICU admission
(Table 1).
On Day 2, sinus tachycardia was resolved and no QT interval
prolongation was seen. However, his chest radiograph showed
collapse of the right upper lung and he had a generalized tonic
clonic seizure (27 hours after hospitalization) which lasted for
45 seconds. The seizure was treated with 5 mg of intravenous
diazepam immediately, followed by 5 mg three times daily and 1 g
of intravenous phenytoin immediately, and then 100 mg three
times daily. The seizure responded to the treatment and the patient
remained seizure free thereafter. The next day, his blood pressure
was persistently low (99/50e100/60 mmHg) despite ﬂuid chal-
lenge, and 0.1 mg/kg/minute of intravenous noradrenaline was
subsequently given. On Day 4, his right upper lung was successfully
re-expanded with chest physiotherapy. His blood pressure
normalized and the noradrenaline was discontinued. On Day 6, the
intravenous phenytoin was discontinued and he was transferred to
the general ward.
3. Discussion
Quetiapine is an atypical antipsychotic which is increasingly
prescribed to a population prone to overdose [6]. Overdoses have
been reported to be less lethal than those from typical antipsy-
chotic agents [6,7]. Quetiapine has a high inhibitory afﬁnity for
serotonergic 5-HT2A receptors and a moderate afﬁnity for dopa-
mine D2-receptors, which mediate its antipsychotic actions with
minimal or no extrapyramidal effects at clinical doses. An appre-
ciable afﬁnity for a1-adrenergic, a2-adrenergic, and histamine H1-
receptors has been observed but it has no signiﬁcant afﬁnity for
antimuscarinic receptors, except at higher doses [1,2]. Central
nervous system depression including somnolence and drowsiness
which are the most common manifestations of quetiapine
poisoning may be related to histamine H1-receptor inhibition.
Hypotension is attributed to antagonism at a1-adrenergic receptors
which leads to vasodilation [1,2]. Tachycardia may be caused by
a reﬂex to vasodilation and interaction at antimuscarinic receptors
which cause vagal blockade to the heart.
A retrospective case series of quetiapine poisoning revealed that
seizures occurred in only 2% of cases but the onset was not reported
[2]. Balit et al reported two cases of seizures in 18 cases of quetia-
pine poisoning, but the onset was only documented in one case,
which was 4 hours post ingestion [1]. A late-onset seizure as in our
case is rarely reported.We found only a case report by Young et al in
which a patient experienced seizures 24 hours after ingesting 30 g
of quetiapine [5]. The form of quetiapine ingested (immediate
release or extended release) was not reported in any of the above-
mentioned case reports [1,2,5]. The immediate release form has
a more rapid rate of absorption and reaches a peak concentration in
about 2 hours compared with 5 hours for the extended-releasetablet [8]. The two formulations have similar clearance proﬁles
with a terminal half-life of approximately 6 hours for the
immediate-release formulation and 7 hours for the sustained-
release formulation [9]. Clinicians should recognize that seizures
can occur with a late onset and at low doses, such as 4 g of
immediate-release quetiapine, as in this case.
Hyperglycemia, as in our case with a random blood glucose of
17.0 mmol/L, is another rarely reported manifestation of quetiapine
overdose. According to the International Diabetes Federation and
American Diabetes Association, a random blood glucose
>7.8 mmol/L [10] or a fasting blood glucose >5.6 mmol/L [11] is
considered hyperglycemia. This symptom was documented in two
case reports. One patient who ingested 36 g of quetiapine pre-
sented with a fasting blood glucose level of 8.96 mmol/L 26 hours
after ingestion [4], whereas the other patient who ingested 9.6 g of
quetiapine presented with a fasting blood glucose level of
7.61 mmol/L approximately 22 hours after ingestion [3]. This
symptom can be explained by quetiapine interaction at seroto-
nergic 5-HT2A receptors (reducing muscle glucose uptake), sero-
tonergic 5-HT2C receptors (mediating insulin resistance) and
muscarinic M3 receptors, which results in dysregulation of insulin
secretion [4].
The range of toxicity of quetiapine overdoses is highly variable
[12]. One patient who ingested 36 g survived with early interven-
tion [4]. Nevertheless, fatalities have been reported and some were
associated with co-ingestion and underlying medical illnesses such
as cardiac dysrhythmias [2]. To date, there is no antidote for que-
tiapine overdose and the cornerstones of management are
supportive care and continous monitoring [12]. Initially, quetiapine
overdose can be treated with activated charcoal, as was done in 82%
of cases in one case series [2]. Hypotension can bemanaged by ﬂuid
resuscitation with normal saline and vasoconstrictors, which have
a high afﬁnity for a receptors, such as noradrenaline and phenyl-
ephrine [12]. Tachycardia and hyperglycemia usually require no
management but warrant continous monitoring. Quetiapine-
induced seizures can be treated the same as status epilepticus
with prompt administration of ﬁrst-line benzodiazepines (lor-
azepam, midazolam, or diazepam) [13]. If seizures recur, additional
administration of a second-line treatment (phenytoin or barbitu-
rate) should be considered [13]. However, the only seizure in our
case was promptly terminated by a combination of benzodiazepine
and phenytoin and the patient remained seizure free with this
regimen.
In conclusion, hyperglycemia and late-onset seizures may occur
after overdoses of 4 g of quetiapine, although there is limited
documentation of this clinical presentation. Clinicians should be
aware of these potential clinical manifestations in quetiapine
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